Skip to main content
Year archive

Mabpharm Limited — 2025 filings

All 27 regulatory filings released by Mabpharm Limited (2181) in 2025, sourced directly from the official regulator.

27 Filings
2025 Period
2025 filings (27)
Filing Released Lang
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Regulatory Filings
2025-12-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change
2025-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings
2025-11-05 English
Terms of Reference of the Nomination Committee
Governance Information
2025-10-31 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information
2025-10-31 English
(1) DESIGNATION OF LEAD INDEPENDENT NON-EXECUTIVE DIRECTOR AND (2) CHANGES IN COMPOSITION OF THE NOMINATION COMMITTEE
Board/Management Information
2025-10-31 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Regulatory Filings
2025-10-03 English
2025 Interim Report
Interim / Quarterly Report H1 2025
2025-09-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings
2025-09-03 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report H2 2025
2025-08-28 English
DATE OF BOARD MEETING
Report Publication Announcement
2025-08-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Share Issue/Capital Change
2025-08-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Regulatory Filings
2025-07-03 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON WEDNESDAY, 18 JUNE 2025
Declaration of Voting Results & Voting Rights Announcements
2025-06-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings
2025-06-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings
2025-05-07 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2025-04-22 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 18, 2025
Proxy Solicitation & Information Statement
2025-04-22 English
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND PROPOSED RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2025-04-22 English
2024 Annual Report
Annual Report FY 2024
2025-04-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Share Issue/Capital Change
2025-04-03 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Release FY 2024
2025-03-26 English
DATE OF BOARD MEETING
Report Publication Announcement
2025-03-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Share Issue/Capital Change
2025-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Regulatory Filings
2025-02-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings
2025-01-06 English
INSIDE INFORMATION ANNOUNCEMENT APPROVAL FROM THE DRUG REGULATORY AUTHORITY OF PAKISTAN ON THE REGISTRATION OF OUR CORE PRODUCT, CMAB008 (INFLIXIMAB FOR INJECTION)
Regulatory Filings
2025-01-02 English